Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

The approach—called GammaTile—involves placing small radiation seeds at a tumor site during surgery.

New radiation therapy treatment stalls recurrence while sparing healthy tissue in patients with brain cancer

The treatment has the potential to “extend lifespans and improve quality of life” in patients with brain cancer, according to experts at UC San Diego Health. 

prostate cancer PSA

MRI/PSA combo cuts down on unnecessary biopsies in patients with suspected PCa

The strategy of combining the two tests improved specificity and positive predictive value in detecting clinically significant cancer compared to PSA alone.  

Thumbnail

'Radiologic serendipity' a common trigger event that ends in thyroid surgery in asymptomatic patients

In this cohort, experts found that just 34% of surgeries were performed on symptomatic patients, which shifted their focus to other potential modes of detection.

Thumbnail

Does the use of PSMA PET impact tumor upstaging?

A new risk analysis suggests the exam will increasingly result in tumor upstaging among high-risk patients.

Thumbnail

AI identifies pancreatic cancer frequently missed on CT

Specifically, the computer-aided detection (CAD) tool is capable of identifying lesions that are less than 2 cm.

Thumbnail

DBT guidance saves time, reduces exposure during breast calcification biopsy

Experts found that opting for DBT-guided biopsy of suspicious breast calcifications could shave up to five minutes off the total procedure time.

neck ultrasound thyroid

Researchers link ultrasound features with risk of thyroid cancer recurrence

In particular, the experts paid close attention to instances of extrathyroidal extension (ETE) on ultrasound. 

Thumbnail

FDG-PET shown to predict pancreatic cancer outcomes prior to surgery, could guide treatment decisions

FDG-PET scans in these patients allow clinicians to determine whether the tumors are still viable or not, thus playing a significant role in making treatment decisions.